Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort
Magali Colombat(Centre Hospitalier Universitaire de Toulouse), Odile Burlet‐Schiltz(Centre National de la Recherche Scientifique), Sophie Georgin‐Lavialle(Inserm), Arnaud François(Université de Rouen Normandie), Anissa Moktefi(Inserm), Gilles Grateau(Sorbonne Université), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Pierre Brousset, Julia Gilhodes(Institut Universitaire de France), Jessica Dalloux-Chioccioli, Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), Elsa Poullot(Assistance Publique – Hôpitaux de Paris), Margot Gaspard, Sophie Valleix(Délégation Paris 5), Jean-Bapiste Gibier, Thibaud Damy(Amyloidosis Foundation), Olivier Lairez(Hôpital Rangueil), Alexis Piedrafita(Inserm), Hervé Maisonneuve(Université d'Angers), Hervé Mal(Université Claude Bernard Lyon 1), Frank Bridoux(Université de Poitiers), Philippe Moreau(Centre National de la Recherche Scientifique), Audrey Delas, Mylène Camus(Centre National de la Recherche Scientifique), Antoine Huart, P Raynaud(Centre Hospitalier de Perpignan)
Cited by 26
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k